Meningococcal Infections
-
Subject Areas on Research
- Atrioventricular-node inflammation--mechanism of sudden death in protracted meningococcemia.
- Bactericidal antibody after colonization with Neisseria meningitidis.
- Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.
- Complement deficiency and sporadic meningococcal disease.
- Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
- Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
- Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system.
- Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
- Marijuana use and social networks in a community outbreak of meningococcal disease.
- Meningococcal disease outbreak associated with disco attendance.
- Meningococcemia and acquired complement deficiency. Association in patients with hepatic failure.
- Meningococcemia in a patient coinfected with hepatitis C virus and HIV.
- Missed opportunities for adolescent vaccination, 2006-2011.
- Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency.
- Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases.
- Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease.
- Rapid bacterial antigen detection is not clinically useful.
- Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older.
- The impact of meningococcal serogroup C conjugate vaccine in Scotland.
- Vaccinations for pregnant women.